Human papillomavirus prevalence and risk factors among Australian women 9-12  years after vaccine program introduction

CONCLUSION: Vaccination has changed the epidemiology of HPV infection in Australian women, having markedly reduced the prevalence of vaccine-targeted types, including amongst women with known risk factors for infection. Vaccinated women appear to be benefiting from modest cross-protection against types 31/33/45 afforded by the quadrivalent HPV vaccine. These results reinforce the importance of HPV vaccination.PMID:34281743 | DOI:10.1016/j.vaccine.2021.07.005

Source: Vaccine - July 20, 2021 Category: Allergy & Immunology Authors: Hannah Shilling Suzanne M Garland Steph Atchison Alyssa M Cornall Julia M L Brotherton Deborah Bateson Kathleen McNamee John M Kaldor Jane S Hocking Marcus Y Chen Christopher K Fairley Anna McNulty Charlotte Bell Lewis Marshall Catriona Ooi S Rachel Skinn Source Type: research